Translation and Cultural Adaptation of the Erasmus Modified Nottingham Sensory Assessment Scale for the Lower Limb in Acquired Brain Injury Into French
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 50
- Locations
- 1
Study Overview
Brief Summary
There is a lack of validated and standardized tools in French for assessing somatosensory perception in adults with brain injuries. The only validated tool in French is the Fugl-Meyer Scale for Sensorimotor Recovery after a Stroke, which assesses only light touch sensitivity in two areas of the arm and leg, as well as proprioception for eight joints. The Erasmus Modified Nottingham Sensory Assessment (EmNSA) offers a detailed assessment of limb somatosensory perception in English. The upper limb (UL) version has been validated in French. The lower limb component remains to be translated and culturally adapted. This cross-cultural translation and adaptation project aims to validate this tool for a comprehensive clinical assessment of somatosensory deficits, applicable in both clinical practice and research. The project aims to validate the study of the metrological qualities (validity and reliability of the scale) of the French version of the EmNSA for the lower limbs.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient with an acquired brain injury attested by brain imaging (CT scan or MRI) of more than seven days
- •Sufficient comprehension ability to participate in the study
- •Patients receiving care in the routine care pathway, as part of rehabilitation or functional assessments available for 6 weeks minimum and 12 weeks maximum
- •Ability to hold attention for at least 30 minutes
- •Aphasia Severity Scale score of 4 or higher
- •Anosognosia Assessment (from the Unilateral Neglect Assessment Battery) score of 1 or lower
Exclusion Criteria
- •Patient with peripheral neurological pathology
- •Severe communication disorders with a score of less than 4 on the Aphasia Severity Scale
- •Anosognosia Assessment (from the Unilateral Neglect Assessment Battery) score of 2 or higher
- •Major attention disorders making it impossible to take stock
- •Patient under guardianship